IFSO 2019 Congress in Madrid

Morbid obesity is a chronic disease

After London 2017 and Dubai 2018, the World Congress of the International Federation of Societies of Obesity Surgery (IFSO) was held this year in the Spanish capital Madrid.

One of the topics was the stigmatisation of overweight patients. There was agreement on this topic that morbid obesity is indeed a chronic disease and requires appropriate treatment. The times when overweight patients are ridiculed, laughed at or even insulted in public must finally be over. With obesity surgery, this group of patients also has access to a variety of different treatments and interventions that can successfully address and permanently treat this condition.

This was an important topic in the meeting of bariatric surgery specialists from the cantons of Switzerland, who had the opportunity to exchange views on this topic at a joint dinner during the congress.

 

What is the state of facts?

In Switzerland, there are primary centres and centres of reference for obesity surgery. Whereas in a primary centre only the first operation for patients with BMI 35-49 may be performed, in a reference centre re-operations (new corrective operations) and very heavy patients (BMI greater than 50) may be operated on. This is an arrangement that makes it difficult for many patients to undergo continuous treatment that is ultimately accompanied by visible, tangible and countable success in the long run.

Swiss1Chirurgie has responded to this together with the Beau-Site clinic in Bern and the Espace Chirurgie clinic in Biel. The obesity surgeons in Biel perform the initial operations at the Hirslanden Klinik Linde and the re-operations with Dr Zehetner at the Klinik Beau-Site.  At the Beau-Site Clinic in Bern alone, 500 of the 4,500 surgical procedures performed annually throughout Switzerland are carried out. At the Centre for Bariatric Surgery in Bern (ZFBC), these patients are pre-cared for, operated on by Swiss1Chirurgie surgeons and then followed up again at the ZFBC. This means that within the Hirslanden network, Swiss1chirurgie has the greatest expertise in bariatric surgery in Switzerland and guarantees the highest level of patient safety.

What patients with problems after obesity surgery can do

Have you already had obesity surgery and are not receiving follow-up care? Or have you put on a massive amount of weight again after the operation and don’t know what to do next?

Ask your general practitioner to refer you to one of our Swiss1Chirurgie locations in Bern, Solothurn or Brig (www.swiss1chirurgie.ch). We can then admit you to our aftercare programme at the Centre for Bariatric Surgery (www.zfbc.ch) or arrange for clarifying examinations for a possible corrective operation to lose weight again.

Of course, the World Congress also focused on the big issues in obesity surgery. Here are a few key points on the results:

  • The most common obesity surgery worldwide is the tube stomach (sleeve).
  • The gastric band is hardly ever done anymore, under 1% of all overweight operations.
  • In patients with reflux, the gastric bypass has advantages over the sleeve.
  • In severely overweight patients, OAGB (one loop anastomosis gastric bypass) is also a possible option.
  • Endoscopic revisions such as anastomotic stenosis with Apollo Overstitch are used more frequently, especially in cases of dumping and recent weight gain.

Learn more? Then simply contact me and let me advise you on the most promising options for the surgical treatment of obesity and reflux disease.

Swiss1Chirurgie informs patients and endocrinologists

New set of rules for obesity surgery

From 01 January 2021, it will be possible to have obesity surgery from a BMI of 30+ with concomitant type 2 diabetes. One of the prerequisites is that diabetes can no longer be safely controlled by conventional means. Only a few specialist clinics are authorised to perform such operations. This also includes the clinics of Swiss1Chirurgie, which offer such procedures in the Helvetia Holding AG network. Learn more about the BAG’s decision.

Overweight surgery possible from BMI 30 with diabetes as of 2021

Being overweight is not something to be trifled with. All those affected know this just as well as we do as medical specialists. For years, the experts at Swiss1Chirurgie have been observing the development of obesity in modern industrialised countries. It is becoming increasingly clear that the proportion of overweight people is growing. Associated with this are not only the individual restrictions and complaints. Healthy societies quickly become sick societies through an oversupply of food at any time in any place and correspondingly wrong nutritional behaviour, whose lack is above all abundance.

So far, health insurers and medical organisations, together with politicians in Switzerland, have agreed that surgical interventions to reduce weight are only possible for a BMI of 35 or higher and are financed accordingly. It was completely ignored that a BMI of 35 or more is already an enormously high value, which is already associated with numerous secondary diseases and complaints. Such concomitant diseases not only complicate the lives of the patients themselves, but are often also a clear obstacle in the preparation and implementation of necessary obesity surgery.

From 2021 the threshold is BMI 30

In accordance with the interventions of the medical specialists and a close observation of the development, the politicians together with the medical profession have decided to lower the threshold value for bariatric surgery in the context of obesity surgery now to a BMI of 30, provided that the patients are affected by diabetes at the same time.

This long overdue decision will benefit patients who, despite being diagnosed with obesity and the corresponding symptoms, were previously not included in the group of patients for whom obesity surgery was an option.

This means that a wide range of conditions closely related to obesity can be treated much sooner and necessary and desired surgical interventions can also be carried out. This will have a lasting impact on the quality of life of people with a BMI over 30 and diabetes, and ultimately reduce the proportion of severely overweight people, along with the social and economic costs.

Advantages especially for humans

The decisive advantages of this decision now lie above all with those people who, with a BMI of 30 or more and diabetes, are already clearly affected by morbid obesity. Now the suffering of these people can be significantly shortened. This is also because it obviously does not make sense to wait for an enormously high BMI of 35 and more until a surgical intervention for weight reduction is made possible by the regulations.

A major advantage of this decision is that the extent of overweight and the associated concomitant and secondary diseases such as diabetes, cardiovascular diseases and arthrosis can be significantly reduced. The psychological suffering can also be significantly shortened and patients with a BMI of 30 or more with diabetes may now place themselves in the hands of the experienced specialists in obesity surgery. The Swiss1Chirurgie clinics are among the specialist medical clinics that will be authorised to perform surgical procedures to reduce excess weight from a BMI of 30 with diabetes from 01.01.2021.

Determine your BMI here and find out whether and under what conditions you belong to the circle of possible candidates for obesity surgery.

TO THE BMI CALCULATOR

In addition, we recommend that all severely overweight people contact a Swiss1Chirurgie clinic. By doing so, you will take the first step towards a better, healthier future in 2021 and use the possibilities of modern medicine to improve your life.

Contact Swiss1Chirurgie here.